IDEXX LABORATORIES INC /DE Lessee, Operating Lease, Liability, to be Paid, after Year Five
IDEXX LABORATORIES INC /DE (IDXX) had Lessee, Operating Lease, Liability, to be Paid, after Year Five of $31.57 million as of 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive · last filed 2026-02-20
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $31.57M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $39.05M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $43.70M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $50.68M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, after Year Five |
|---|---|
| 2025-12-31 | $31.57M 10-K · filed 2026-02-20 |
| 2024-12-31 | $39.05M 10-K · filed 2025-02-21 |
| 2023-12-31 | $43.70M 10-K · filed 2024-02-22 |
| 2022-12-31 | $50.68M 10-K · filed 2023-02-16 |
| 2021-12-31 | $39.05M 10-K · filed 2022-02-16 |
| 2020-12-31 | $39.22M 10-K · filed 2021-02-12 |
| 2020-06-30 | $35.74M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $33.38M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $33.60M 10-K · filed 2020-02-14 |
| 2019-09-30 | $38.40M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $38.38M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $37.72M 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |